Clinical trials start for ABI’s breath asthma check rapid assay – Stock Market Wire

Clinical trials start for ABI's breath asthma check rapid assay
Stock Market Wire
StockMarketWire.com – Clinical trials for Akers Biosciences' breath asthma check rapid assay have begun in Clearwater, Florida. The trials have been designed to provide the clinical information to be included in a submission for regulatory approvals
18 APRIL 2011 Akers Biosciences* AKR (FTSE AIM All Share) 4p BUY (TP-10p)AngelNews (press release) (subscription)

all 3 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *